Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway
机构:[1]The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China深圳市中医院深圳医学信息中心[2]Department of Traditional Chinese Medicine, Nanfang Hospital (ZengCheng Branch), Southern Medical University, Guangzhou, 510515, China[3]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China[4]Binzhou Medical University Hospital, Binzhou, 256603, China[5]Department of Hepatology, Cancer Center, Integrated Hospital of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510315, China[6]The Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital), Dongguan, 523058, China[7]Department of Cardiovascular Medicine, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China深圳市中医院深圳医学信息中心[8]The First Affiliated Hospital of Guangzhou University of Chinese Medicine/Post- Doctoral Research Station, Guangzhou, 510405, China深圳市中医院深圳医学信息中心[9]Guangdong Clinical Research Academy of Chinese Medicine, Guangzhou, 510405, China[10]Department of Traditional Chinese Medicine, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, 510260, China[11]Department of Traditional Chinese Medicine, Yangjiang People’s Hospital, Yangjiang, 529599, China[12]Department of Acupuncture and Moxibustion, The Affliated TCM Hospital of Guangzhou Medical University, Guangzhou, 510130, China[13]Department of Obstetrics and Gynecology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, China深圳市中医院深圳医学信息中心
This research was supported by the following grants: National Natural Science Foundation of China (Nos. 82274417, 82204959, 82305110, 82305225, 82004103, 82104968), Chinese Postdoctoral Science Foundation (No. 2022M711538), Guangdong Basic and Applied Basic Research Foundation (Nos. 2022A1515011630, 2022A1515110870, 2021A1515220010, 2021A1515110786, 2022A1515011668), Dongguan Science and Technology of Social Development Program (No. 20231800932382), Young Scientifc and Technical Talents Project of The Affliated TCM Hospital of Guangzhou Medical University (No. 2022RC02), Science and Technology Project of Guangzhou City (No. 202201011196).
第一作者机构:[1]The First School of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China
共同第一作者:
通讯作者:
通讯机构:[2]Department of Traditional Chinese Medicine, Nanfang Hospital (ZengCheng Branch), Southern Medical University, Guangzhou, 510515, China[3]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, China[*1]Department of Traditional Chinese Medicine, Nanfang Hospital (ZengCheng Branch), Southern Medical University, Guangzhou, 510515, China.
推荐引用方式(GB/T 7714):
Chen Hongmei,Zhang Guoyong,Peng Yan,et al.Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway[J].JOURNAL OF ETHNOPHARMACOLOGY.2024,323:117718.doi:10.1016/j.jep.2024.117718.
APA:
Chen Hongmei,Zhang Guoyong,Peng Yan,Wu Yuting,Han Xin...&Luo Songping.(2024).Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway.JOURNAL OF ETHNOPHARMACOLOGY,323,
MLA:
Chen Hongmei,et al."Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway".JOURNAL OF ETHNOPHARMACOLOGY 323.(2024):117718